LINC00112: A Drug Target / Disease Biomarker (G54089)

Target Name: LINC00112

NCBI ID: G54089

LINC00112

Other Name(s): C21orf22 | Long intergenic non-protein coding RNA 112 | NCRNA00112 | long intergenic non-protein coding RNA 112

LINC00112: A Drug Target / Disease Biomarker

LINC00112 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. LINC00112 is a small non-coding RNA molecule that is known to play a role in the regulation of gene expression in various organisms.

Recent studies have suggested that LINC00112 may have a variety of functions, including regulating the expression of genes involved in cell growth and differentiation, and influencing the development of cancer. LINC00112 has also been shown to be involved in the regulation of inflammation and immune responses.

One of the key features of LINC00112 is its ability to interact with a variety of different proteins, including transcription factors, RNA factors, and protein-coding genes. This interaction with other proteins allows LINC00112 to regulate gene expression and influence a wide range of cellular processes.

In addition to its potential role as a drug target, LINC00112 has also been identified as a potential biomarker for a number of diseases. For example, LINC00112 has been shown to be elevated in the blood samples of patients with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that LINC00112 may be a useful biomarker for these diseases.

Another potential application of LINC00112 as a drug target is its role in the regulation of cell signaling pathways. LINC00112 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, a pathway that is involved in the regulation of cell growth, differentiation, and survival.

In addition to its potential role in cell signaling pathways, LINC00112 has also been shown to have a variety of other functions. For example, LINC00112 has been shown to play a role in the regulation of gene expression in the immune system, influencing the development of cancer and autoimmune disorders.

Overall, LINC00112 is a fascinating molecule that has a wide range of potential applications, including as a drug target and biomarker. Further research is needed to fully understand the functions of LINC00112 and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 112

The "LINC00112 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00112 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets